血浆制品对创伤-失血性休克后内皮糖萼屏障的保护作用:1-磷酸鞘氨醇是否关键
本研究利用人脐静脉内皮细胞微流控模型,模拟创伤-失血性休克(缺氧/复氧+肾上腺素10 μM)后的微循环环境,观察新鲜血浆、融化1天血浆、融化5天血浆和冻干血浆对内皮糖萼及内皮损伤/活化的影响。结果显示,休克条件增加syndecan-1和透明质酸脱落,除融化5天血浆外各型血浆均减少脱落,并使纤溶亢进表型正常化;融化5天血浆S-1P浓度显著低于其他血浆,补充S-1P可恢复其丢失的保护作用。作者认为S-1P蛋白对血浆制品保护内皮糖萼屏障至关重要。
要点
- 休克条件(缺氧/复氧+肾上腺素10 μM)下内皮细胞syndecan-1和透明质酸脱落增加,除融化5天血浆外各型血浆均减少脱落。
- 休克内皮细胞呈纤溶亢进表型,除融化5天血浆外各型血浆均使其正常化。
- 融化5天血浆的S-1P浓度显著低于其他血浆类型,补充S-1P可恢复其丢失的保护作用。
- 作者认为S-1P蛋白对血浆制品保护创伤-失血性休克后内皮糖萼屏障至关重要。
适用人群与场景
- 体外研究:人脐静脉内皮细胞(HUVEC)在微流控板中培养,模拟创伤-失血性休克后微循环环境
诊断标准与关键阈值
- 休克条件:缺氧/复氧+肾上腺素10 μM
- 内皮糖萼脱落指标:syndecan-1和透明质酸脱落
- 内皮损伤/活化指标:可溶性血栓调节蛋白、组织型纤溶酶原激活物、纤溶酶原激活物抑制剂-1
- 血管通透性:血管生成素-2与血管生成素-1比值
处置流程与药物剂量
- 休克条件下分别加入新鲜血浆、融化1天血浆、融化5天血浆或冻干血浆
- 部分实验补充S-1P
- 检测各血浆组S-1P和脂联素浓度
研究设计与关键结果
- 体外微流控模型研究:HUVEC暴露于休克条件后syndecan-1和透明质酸脱落增加。
- 除融化5天血浆外,各型血浆均减少syndecan-1和透明质酸脱落。
- 休克HUVEC呈纤溶亢进表型,除融化5天血浆外各型血浆均使其正常化。
- 融化5天血浆S-1P浓度显著低于其他血浆类型。
- 向融化5天血浆补充S-1P可恢复因储存丢失的保护作用。
证据类型、等级与局限
- 证据类型:体外微流控模型研究
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为S-1P蛋白对血浆制品保护创伤-失血性休克后内皮糖萼屏障至关重要。
- 体外模型提示融化5天血浆的内皮保护作用减弱,补充S-1P可恢复该作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Plasma is an important component of resuscitation after trauma and hemorrhagic shock (T/HS). The specific plasma proteins and the impact of storage conditions are uncertain. Utilizing a microfluidic device system, we studied the effect of various types of plasma on the endothelial barrier function following T/HS.
METHODS: Human umbilical vein endothelial cells (HUVEC) were cultured in microfluidic plates. The microfluidic plates were subjected to control or shock conditions (hypoxia/reoxygenation + epinephrine, 10 μM). Fresh plasma, 1 day thawed plasma, 5-day thawed plasma and lyophilized plasma were then added. Supplementation of sphingosine-1 phosphate (S-1P) was done in a subset of experiments. Effect on the endothelial glycocalyx was indexed by shedding of syndecan-1 and hyaluronic acid. Endothelial injury/activation was indexed by soluble thrombomodulin, tissue plasminogen activator, plasminogen activator inhibitor-1. Vascular permeability determined by the ratio of angiopoietin-2 to angiopoietin-1. Concentration of S-1P and adiponectin in the different plasma groups was measured.
RESULTS: Human umbilical vein endothelial cells exposed to shock conditions increased shedding of syndecan-1 and hyaluronic acid. Administration of the various types of plasma decreased shedding, except for 5-day thawed plasma. Shocked HUVEC cells demonstrated a profibrinolytic phenotype, this normalized with all plasma types except for 5-day thawed plasma. The concentration of S-1P was significantly less in the 5-day thawed plasma compared with the other plasma types. Addition of S-1P to 5-day thawed plasma returned the benefits lost with storage.
CONCLUSION: A biomimetic model of the microcirculation following T/HS demonstrated endothelial glycocalyx and endothelial cellular injury/activation as well as a profibrinolytic phenotype. These effects were abrogated by all plasma products except the 5-day thawed plasma. Plasma thawed longer than 5 days had diminished S1-P concentrations. Our data suggest that S1-P protein is critical to the protective effect of plasma products on the endothelial-glycocalyx barrier following T/HS.
参考来源
- Diebel ME, Diebel LN, Liberati DM, et al. Protective effects of plasma products on the endothelial-glycocalyx barrier following trauma-hemorrhagic shock: Is sphingosine-1 phosphate responsible? J Trauma Acute Care Surg. 2019. PMID: 31453986. doi:10.1097/TA.0000000000002446
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。